Fig. 1
From: Clinical application of liquid biopsy in cancer patients
Identifying CH variants in plasma cfDNA via matched WBC sequencing. a Percentage of plasma samples with identified CH variants in different cancer types. The first row indicates the overall percentage of samples with CH variants in different cancer types. The remaining rows indicate the percentage of samples with CH variants in recurrent and canonical genes. b Percentage of plasma samples with identified CH variants in controls